Drug regulator gives approval for FDCs licenced before 1988
Source: The mint New Delhi: The Central Drugs Standard Control Organization (CDSCO) has allowed companies to manufacture and market five fixed dose combinations (FDCs) that were banned last year. The permission comes with certain conditions, as per a notice issued by Dr Rajeev Raghuvanshi, Drugs Controller General of India (DCGI). An expert committee headed by […]
Pharmaways Marks Milestone: Expands Presence to 100 Countries
Written: Abid Ali Khan Pharmaways, the leading pharmaceutical search engine, is celebrating a significant achievement with its expansion into 100 countries worldwide. This milestone solidifies Pharmaways’ position as a go-to resource for stakeholders within the pharmaceutical industry. The platform’s user-friendly interface and advanced search capabilities cater specifically to the needs of professionals, researchers, and decision-makers […]
CDSCO Drug Alert: 78 Drug Samples including Alkems Pan 40 Flagged
Source: Medical Dialogues New Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drug Standard Control Organisation (CDSCO) has flagged 78 medicine batches for failing to qualify for a random drug sample test for December– 2023. These include Montelukast Sodium and Levocetirizine Dihydrochloride Tablets manufactured by Bonsai Pharma, Multi-Vitamin Tablets (VITAJACKS-S TABLETS) […]
Key Trends Shaping the Future of Indian Pharma in 2024
In 2023, the Indian pharmaceutical industry underwent significant transformation, emerging as the third largest globally by volume and exporting to over 200 countries. Valued at $50 billion, the sector has immense potential, forecasted to reach $120-130 billion in the next decade driven by innovation. Key trends driving this transformation include: With a focus on compliance, […]
‘Cannot Export Products Made for Sale in Indian Market’: Health Regulator Issues Alert
Source: News18 Products made for the Indian market cannot be exported, the central health regulator has said in an alert issued to all of its port offices across India, asking them to watch the exports by merchant exporters, News18 has learnt. While the notice does not mention the objective behind the move, two government officials told News18 that the […]
Indian pharma eyes ease of shared regulatory framework
Source: Pharmabiz The Indian pharmaceutical industry is eyeing the seamless applicability of its expertise into nutraceutical research and manufacture which is underscored by the shared regulatory frameworks and quality standards of the two sectors. Indian pharmaceutical companies, which are now considering a foray into nutraceutical market, have recognised there is an untapped potential. This transformative […]
API Market to reach a USD 839.1 Billion by 2033
Source: Yahoo Finance The global demand for pharmaceutical products, including both branded and generic drugs, has been steadily rising. As a result, the need for active pharmaceutical ingredients, which are the essential components of these medications, has grown substantially. New York, Jan. 23, 2024 (GLOBE NEWSWIRE) — According to Market.us, the global Active Pharmaceutical Ingredient market size […]
Solan: Pharma hub without State Drugs Controller since Jan 1
Source: Tribune India Even as the Baddi-Barotiwala-Nalagarh (BBN) industrial cluster is acclaimed as the pharmaceutical hub of Asia, the drugs control administration (DCA) has been functioning without a State Drugs Controller (SDC) since January 1. The post fell vacant on December 31 after incumbent Navneet Marwaha superannuated. The state government has failed to appoint an […]
Domestic pharma market grew by 6.8% in 2023
Source: rediff The Indian pharmaceutical market (IPM) grew 6.8 per cent to touch a turnover of ~1.93 trillion in calendar year 2023, despite volumes going down marginally by 0.9 per cent. Growth in the moving annual turnover (the previous 12 months’ turnover) in December was 5.1 per cent and that in new product introduction 2.6 […]
After prohibiting FDC for kids under 4, regulator scrutinize other remedies
India’s apex drug regulator, the Central Drugs Standard Control Organisation (CDSCO), last month instructed drugmakers not to sell a popular fixed dose combination (FDC) medicine, indicated as a cough syrup, for kids under the age of four. While the 18 December notice mentioned the combination of chlorpheniramine maleate and phenylephrine hydrochloride, other FDCs marketed as […]